COYA
Price
$4.86
Change
-$0.40 (-7.60%)
Updated
Jul 13 closing price
Capitalization
113.88M
35 days until earnings call
Intraday BUY SELL Signals
GANX
Price
$1.76
Change
-$0.04 (-2.22%)
Updated
Jul 13 closing price
Capitalization
74.64M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COYA vs GANX

COYA vs GANX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COYA vs. GANX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Buy and GANX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (COYA: $4.86 vs. GANX: $1.76)
Brand notoriety: COYA and GANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 133% vs. GANX: 101%
Market capitalization -- COYA: $113.88M vs. GANX: $74.64M
COYA [@Biotechnology] is valued at $113.88M. GANX’s [@Biotechnology] market capitalization is $74.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 1 FA rating(s) are green whileGANX’s FA Score has 0 green FA rating(s).

  • COYA’s FA Score: 1 green, 4 red.
  • GANX’s FA Score: 0 green, 5 red.
According to our system of comparison, COYA is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 3 TA indicator(s) are bullish while GANX’s TA Score has 5 bullish TA indicator(s).

  • COYA’s TA Score: 3 bullish, 6 bearish.
  • GANX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GANX is a better buy in the short-term than COYA.

Price Growth

COYA (@Biotechnology) experienced а -15.71% price change this week, while GANX (@Biotechnology) price change was -2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

COYA is expected to report earnings on Aug 18, 2026.

GANX is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COYA($114M) has a higher market cap than GANX($74.6M). COYA YTD gains are higher at: -16.293 vs. GANX (-45.342). GANX has higher annual earnings (EBITDA): -19.6M vs. COYA (-22.5M). COYA has more cash in the bank: 50.7M vs. GANX (16.5M). COYA has higher revenues than GANX: COYA (7.94M) vs GANX (0).
COYAGANXCOYA / GANX
Capitalization114M74.6M153%
EBITDA-22.5M-19.6M115%
Gain YTD-16.293-45.34236%
P/E RatioN/AN/A-
Revenue7.94M0-
Total Cash50.7M16.5M307%
Total DebtN/A672K-
TECHNICAL ANALYSIS
Technical Analysis
COYAGANX
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 21 days ago
86%
Bullish Trend 28 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signal:
Gain/Loss:
GANX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TCGRX36.82N/A
N/A
Thornburg Focus Growth R4
AIEMX16.30N/A
N/A
Alger Emerging Markets I
DCUSX16.09N/A
N/A
DWS CROCI US S
PRPHX73.47N/A
N/A
Permanent Portfolio Permanent C
MVISX60.67N/A
N/A
Patient Opportunity IS

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with HOWL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then HOWL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
-2.22%
HOWL - GANX
43%
Loosely correlated
-15.26%
COYA - GANX
41%
Loosely correlated
-7.70%
AXON - GANX
36%
Loosely correlated
-3.32%
VIR - GANX
35%
Loosely correlated
-2.41%
VERA - GANX
35%
Loosely correlated
-1.19%
More